Richard A. Morgan
Direktor/Vorstandsmitglied bei American Society of Gene & Cell Therapy
Profil
Richard A.
Morgan is currently the Director at the American Society of Gene & Cell Therapy.
Prior to this, he was the Senior Vice President-Immunogenetics at Editas Medicine, Inc. from 2018 to 2021.
He received his undergraduate degree from Brandeis University and his doctorate from The Johns Hopkins University.
Aktive Positionen von Richard A. Morgan
Unternehmen | Position | Beginn |
---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Richard A. Morgan
Unternehmen | Position | Ende |
---|---|---|
EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01.02.2021 |
Ausbildung von Richard A. Morgan
The Johns Hopkins University | Doctorate Degree |
Brandeis University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EDITAS MEDICINE, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |